Their first product, Illuccix, is a diagnostic imaging agent that allows PET scanners to light up the prostate cancer cells ...

These payments to super come from your pre-tax income and include Superannuation Guarantee payments. You could contribute up ...

Biotech stumbled in FY25, but we didn’t. HB Biotechnology kept its footing and delivered 23% outperformance in a tough market ...

Explore U.S. economic trends: growth uncertainty and rising inflation risks.

In a market full of flashy tech and speculative growth stories, here's a refreshingly grounded stock to watch.

The RBA’s proposed surcharge ban and fee caps may reshape payments, but Visa and Mastercard are already positioned for the ...

Over the last 12 months to 30 June 2025, Bloomberg data revealed that CBA alone accounted for 33% of the S&P/ASX 200’s total ...

ARK strives to invest at the pace of innovation. The ARK Global Disruptive Innovation Fund aims to achieve a target average ...

Greg Sharenow, managing director and portfolio manager, charts the continued resilience of commodities and their low ...

While markets chase the AI hype, medtech quietly trades at decade-lows. Here’s why that’s an opportunity for long-term ...

By learning to avoid mistakes you can improve your returns as much by learning what qualities to look for in a business.

Rational investors have abandoned CBA, resulting in a share price that gets 'pushed around' by passive and momentum flows.